What is the appropriate management for an 11-year-old female taking lurasidone (Latuda) 80 mg daily and lithium carbonate 450 mg twice daily who has a fasting triglyceride level of 370 mg/dL?

Management of Hypertriglyceridemia in an 11-Year-Old on Latuda and Lithium

The immediate priority is to address the medication-induced hypertriglyceridemia by implementing aggressive lifestyle modifications and strongly considering switching from Latuda to an alternative antipsychotic with a more favorable metabolic profile, as atypical antipsychotics are a known cause of elevated triglycerides and this patient's level of 370 mg/dL places her in the moderate hypertriglyceridemia category requiring intervention.

Understanding the Clinical Context

This 11-year-old has triglycerides of 370 mg/dL, which falls into the moderate hypertriglyceridemia category (175-499 mg/dL) 1. While the primary concern at levels ≥500 mg/dL is pancreatitis prevention, at 370 mg/dL the focus is on reducing long-term atherosclerotic cardiovascular disease (ASCVD) risk and preventing progression to severe hypertriglyceridemia 1.

Critically, atypical antipsychotic drugs are explicitly listed as triglyceride-raising medications in the 2018 AHA/ACC guidelines 1. The FDA label for Latuda confirms this concern, showing mean triglyceride increases of +8.5 mg/dL at the 80 mg/day dose in adolescents 2. Recent meta-analytic evidence demonstrates that lurasidone causes decreased triglyceride levels compared to placebo in some studies, but olanzapine and quetiapine are far worse offenders 3.

Step 1: Identify and Address Secondary Causes (Class I Recommendation)

The 2018 AHA/ACC guidelines provide a Class I, Level B-NR recommendation to address medications that increase triglycerides in patients with moderate hypertriglyceridemia 1. This is the highest level of recommendation.

Specific actions:

• Evaluate if Latuda can be switched to a more metabolically neutral antipsychotic. Lurasidone is actually among the better-tolerated antipsychotics for metabolic effects 3, but the combination with lithium may be contributing. Aripiprazole or ziprasidone would be preferred alternatives if clinically appropriate 3.
• Assess lithium levels and thyroid function - lithium can cause hypothyroidism, which is a secondary cause of hypertriglyceridemia 1.
• Screen for diabetes mellitus, obesity/metabolic syndrome, and other secondary causes (chronic liver or kidney disease) 1.

Step 2: Implement Aggressive Lifestyle Modifications

For pediatric patients with triglycerides >150 mg/dL, the American Heart Association pediatric guidelines recommend specific targets 4:

Dietary interventions (refer to registered dietitian):

• Reduce simple sugars and refined carbohydrates - this is critical for triglyceride reduction
• Limit total fat intake to 20-25% of calories (for TG 175-499 mg/dL range) 5
• Reduce saturated fat to <7% of total calories
• Increase soluble fiber: age in years + 5-10 grams daily (for an 11-year-old: 16-21 grams/day) 4
• Add plant sterols/stanols 2 g/day - shown to reduce LDL-C by 8-10% 4, 6
• Increase omega-3 fatty acid intake through fish (not supplements in children without severe hypertriglyceridemia) 4

Physical activity:

• 30-60 minutes of moderate-intensity aerobic activity daily 4
• Address any obesity with family-centered behavioral weight management 4

Step 3: Monitor and Reassess

Recheck fasting lipid panel in 3 months after implementing lifestyle changes and any medication adjustments 4, 6. The Canadian guidelines recommend averaging at least 2 fasting lipid profiles obtained 2 weeks to 3 months apart before making treatment decisions 6.

Step 4: Pharmacologic Therapy Considerations

At this triglyceride level (370 mg/dL) in an 11-year-old, pharmacologic therapy beyond addressing the causative medication is NOT yet indicated 4, 7. The pediatric guidelines are clear:

• No pharmacological interventions are recommended in children for isolated elevation of fasting TG unless >400 mg/dL (to protect against postprandial TG >1,000 mg/dL and pancreatitis risk) 4
• If TG remains >400 mg/dL despite lifestyle modifications and medication adjustment, fibrate therapy may be considered in collaboration with a pediatric lipid specialist 4, 7
• Statins are not first-line for isolated hypertriglyceridemia in children 7

Critical Pitfalls to Avoid

1. Do not start fibrates or other lipid-lowering drugs at this TG level (370 mg/dL) without first addressing the medication cause and implementing lifestyle changes - this violates guideline recommendations 1, 4

2. Do not ignore the medication contribution - the guidelines explicitly state that addressing triglyceride-raising medications is a Class I recommendation 1

3. Do not use bile acid sequestrants - these are relatively contraindicated when triglycerides are >200 mg/dL as they can worsen hypertriglyceridemia 8

4. Do not delay referral to a registered dietitian - medical nutrition therapy is the cornerstone of management and requires specialized expertise 5, 6

5. Do not use omega-3 supplements at this level - dietary omega-3 from fish is preferred; high-dose supplements (2-4 g/day) are reserved for severe hypertriglyceridemia 4, 9

Monitoring for Progression

If triglycerides approach or exceed 500 mg/dL despite interventions, the risk profile changes significantly toward pancreatitis prevention, requiring more aggressive fat restriction (10-15% of calories) and possible fibrate therapy 5. At levels ≥1,000 mg/dL, extreme dietary fat restriction (<5% of calories) may be necessary 5.

1 1 1 4 5 6 2 7 3